These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 29068)

  • 1. Selective sensitivity to hydrocortisone of regulatory functions that determine the magnitude of the antibody response to type III pneumococcal polysaccharide.
    Markham RB; Stashak PW; Prescott B; Amsbaugh DF; Baker PJ
    J Immunol; 1978 Sep; 121(3):829-34. PubMed ID: 29068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of concanavalin A on lymphocyte interactions involved in the antibody response to type III pneumococcal polysaccharide. II. Ability of suppressor T cells to act on both B cells and amplified T cells to limit the magnitude of the antibody response.
    Markham RB; Reed ND; Stashak PW; Prescott B; Amsbaugh DF; Baker PJ
    J Immunol; 1977 Sep; 119(3):1163-8. PubMed ID: 19533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of splenectomy on the expression of regulatory T cell activity.
    Amsbaugh DF; Prescott B; Baker PJ
    J Immunol; 1978 Oct; 121(4):1483-5. PubMed ID: 29928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the antibody response to type III pneumococcal polysaccharide. V. Ontogeny of factors influencing the magnitude of the plaque-forming cell response.
    Morse HC; Prescott B; Cross SS; Stashak PW; Baker PJ
    J Immunol; 1976 Feb; 116(2):279-87. PubMed ID: 2633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of amplifier T cells involved in the antibody response to the capsular polysaccharide of type III Streptococcus pneumoniae.
    Taylor CE; Stashak PW; Chiang J; Leiserson WM; Caldes G; Prescott B; Baker PJ
    J Immunol; 1984 Jun; 132(6):3103-8. PubMed ID: 6202773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of amplifier T cells involved in the antibody response to type III pneumococcal polysaccharide to anti-lymphocyte serum.
    Markham RB; Stashak PW; Prescott B; Amsbaugh DF; Baker PJ
    J Immunol; 1977 Sep; 119(3):1159-62. PubMed ID: 19532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct evidence for the involvement of T suppressor cells in the expression of low-dose paralysis to type III pneumococcal polysaccharide.
    Baker PJ; Amsbaugh DF; Stashak PW; Caldes G; Prescott B
    J Immunol; 1982 Mar; 128(3):1059-62. PubMed ID: 6173416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface antigens and other characteristics of T cells regulating the antibody response to type III pneumococcal polysaccharide.
    Taylor CE; Amsbaugh DF; Stashak PW; Caldes G; Prescott B; Baker PJ
    J Immunol; 1983 Jan; 130(1):19-23. PubMed ID: 6600175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of soluble suppressor factor by spleen cells from mice immunized with type III pneumococcal polysaccharide.
    Taylor CE; Baker PJ
    J Immunol; 1985 Oct; 135(4):2551-6. PubMed ID: 2411801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirements for activation of contrasuppressor T cells by type III pneumococcal polysaccharide.
    Braley-Mullen H
    J Immunol; 1986 Jan; 136(2):396-401. PubMed ID: 2867113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Models for assessing the effect of toxicants on immunocompetence in mice. II. Effect of cyclophosphamide on the antibody responses to type III pneumococcal polysaccharide and tetanus toxoid in BALB/c female mice.
    Speirs RS; Benson RW; Knowles BJ; Roberts D
    J Environ Pathol Toxicol; 1978; 1(6):791-812. PubMed ID: 32218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct demonstration of specific suppressor T cells in the mice tolerant to type III pneumococcal polysaccharide: two-step requirement for development of detectable suppressor cells.
    Braley-Mullen H
    J Immunol; 1980 Oct; 125(4):1849-54. PubMed ID: 6157748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two defects in old New Zealand Black mice are involved in the loss of low-dose paralysis to type III pneumococcal polysaccharide.
    McCoy KL; Baker PJ; Stashak PW; Chused TM
    J Immunol; 1985 Oct; 135(4):2438-42. PubMed ID: 3875654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the antibody response to pneumococcal polysaccharide by thymus-derived cells.
    Baker PJ; Amsbaugh DF; Stashak PW; Caldes G; Prescott B
    Rev Infect Dis; 1981; 3(2):332-41. PubMed ID: 6973183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of concanavalin A on lymphocyte interactions involved in the antibody response to type III pneumococcal polysaccharide I. Comparison of the suppression induced by con A and low dose paralysis.
    Markham RB; Stashak PW; Prescott B; Amsbaugh DF; Baker PJ
    J Immunol; 1977 Mar; 118(3):952-6. PubMed ID: 15032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the antibody response to type 3 pneumococcal polysaccharide. IV. Role of suppressor T cells in the development of low-dose paralysis.
    Baker PJ; Stashak PW; Amsbaugh DF; Prescott B
    J Immunol; 1974 Jun; 112(6):2020-7. PubMed ID: 4151107
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulatory role of T cells in IgG antibody formation and immune memory to type III Pneumococcal polysaccharide.
    Braley-Mullen H
    J Immunol; 1974 Dec; 113(6):1909-20. PubMed ID: 4154347
    [No Abstract]   [Full Text] [Related]  

  • 18. Examination of the differential characteristics of amplifier and contrasuppressor T cells.
    Baker PJ; Fauntleroy MB; Prescott B
    Immunobiology; 1988 Sep; 177(4-5):438-48. PubMed ID: 2904409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of various adjuvants on the antibody response of mice to pneumococcal polysaccharides.
    Yin JZ; Bell MK; Thorbecke GJ
    J Biol Response Mod; 1989 Apr; 8(2):190-205. PubMed ID: 2659742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of T cell independent and cross-reactive antigen on the immune response to pneumococcal conjugate vaccination.
    Rabquer B; Smithson SL; Shriner A; Julie Westerink MA
    Immunol Lett; 2006 Aug; 106(2):187-90. PubMed ID: 16781780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.